Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations (Unaudited)

v3.26.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Costs and expenses:        
Research and development $ 85
General and administrative 1,742 1,577 5,232 5,275
Total operating expenses 1,742 1,577 5,232 5,360
Loss from operations (1,742) (1,577) (5,232) (5,360)
Other income (loss):        
Change in fair value of the warrant liability (3,161)
(Loss) gain on disposal of assets (138) 110
Gain on lease termination, net 368
Other income (expense), net (23) 45 (10) (22)
Other (loss) income, net (23) 45 220 (3,073)
Net loss (1,765) (1,532) (5,012) (8,433)
Deemed dividend due to Series C Preferred down-round (2,372) (2,372)
Deemed dividend due to 2025 Warrant down-round (1,208) (1,208)
Deemed dividend due to issuance of inducement warrants (3,541) (3,541)
Deemed dividend relating to warrant exchange (618) (618)
Net loss attributable to common stockholders $ (8,886) $ (2,150) $ (12,133) $ (9,051)
Net loss per share - basic $ (9.35) $ (5.93) $ (20.11) $ (26.09)
Net loss per share - diluted $ (9.35) $ (5.93) $ (20.11) $ (26.09)
Weighted Average Number of Shares Outstanding, Diluted [1] 950,612 362,388 603,476 346,969
[1] Adjusted to reflect the impact of the 1-for-15 reverse stock split effective September 28, 2026.